Total Holdings
26
Portfolio diversification across 26 positions

Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
View ticker symbols, company names, asset types, and allocation percentages for each position
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Gilead Sciences, Inc. | Stock | 16.38% |
| 2 | ![]() | Amgen Inc. | Stock | 16.14% |
| 3 | ![]() | Vertex Pharmaceuticals Incorporated | Stock | 9.05% |
| 4 | ![]() | Regeneron Pharmaceuticals, Inc. | Stock | 7.42% |
| 5 | ![]() | Insmed Incorporated | Stock | 5.42% |
| 6 | ![]() | Natera, Inc | Stock | 5.16% |
| 7 | ![]() | argenx NV ADR | Stock | 5.06% |
| 8 | ![]() | IQVIA Holdings Inc | Stock | 4.78% |
| 9 | B BGNE | BeiGene, Ltd | Stock | 3.89% |
| 10 | ![]() | Alnylam Pharmaceuticals, Inc | Stock | 3.85% |
| 11 | ![]() | Biogen Inc | Stock | 3.65% |
| 12 | ![]() | BeOne Medicines AG | Stock | 3.51% |
| 13 | ![]() | United Therapeutics Corporation | Stock | 3.49% |
| 14 | ![]() | Illumina, Inc | Stock | 2.90% |
| 15 | ![]() | ICON Public Limited Company | Stock | 2.85% |
| 16 | ![]() | Incyte Corporation | Stock | 2.37% |
| 17 | ![]() | Exact Sciences Corporation | Stock | 2.24% |
| 18 | ![]() | Neurocrine Biosciences, Inc | Stock | 2.20% |
| 19 | ![]() | Moderna, Inc. | Stock | 2.20% |
| 20 | ![]() | BioNTech SE | Stock | 2.04% |
| 21 | ![]() | QIAGEN N.V | Stock | 1.66% |
| 22 | ![]() | Bio-Techne Corporation | Stock | 1.63% |
| 23 | ![]() | Tempus AI, Inc. Class A Common Stock | Stock | 1.55% |
| 24 | ![]() | Repligen Corporation | Stock | 1.39% |
| 25 | ![]() | Charles River Laboratories International, Inc. | Stock | 1.34% |
| 26 | ![]() | BioMarin Pharmaceutical Inc | Stock | 1.31% |